Serimmune

Immune intelligence company

[Serimmune @serimmune]

Attending AACR 2024? Be sure to stop by our poster presentation on the development of a B-cell epitope classifier for early detection of renal cell carcinoma 4/7 from 1:30-5PM
https://t.co/8eQ2dtfgHL
#aacr24 #biomarkers #antibody #oncology

[Serimmune @serimmune]

In case you missed it check out this news release about our recent publication from Moderna utilizing our SERA platform to study the antibody response to mRNA-1273 vaccine and boosters #COVID_19 #mRNA #moderna
https://t.co/ZQNStJUWcV

[Serimmune @serimmune]

Attending World Vaccine Congress this week? Be sure to stop by our booth 630 and learn about how our SERA platform is being used to assess vaccines #WVCDC #WVC2024 https://t.co/1LccfHbD4t

[Serimmune @serimmune]

Excited to share this paper with @moderna_tx using our SERA assay to study the antibody immune response to mRNA COVID-19 vaccines #antibody #vaccines
https://t.co/4YheW31BLA

[Serimmune @serimmune]

Happy New Year from #TeamSerimmune! We look forward to another packed year as we strive to bring innovations to research with our #SERA platform.

[Serimmune @serimmune]

Wishing you a safe, happy holiday season from all of us at #TeamSerimmune! We hope you take time to rest and recharge with your families as we charge up for an exciting year.

[Serimmune @serimmune]

Another great highlight of 2023 was having our CTO John Shon interview with Biocompare in November to walk through #immunoassays and their applications with other industry experts. Check it out: https://t.co/qFunmOLsAJ

#immunology

[Serimmune @serimmune]

We’re wrapping up an exciting year at Serimmune! Highlight #1: having our #SERA platform used in a breakthrough #LongCOVID study from Dr. Akiko Iwasaki & team in @Nature: https://t.co/Vo3UESIkly

We look forward to other research advancements in 2024!

#immuneprofiling

[Serimmune @serimmune]

Our Serum Epitope Repertoire Analysis (SERA) platform is a 10 billion bacterial display peptide array that functions as a universal serology assay." Explore how our #SERA platform can maximize #research in the latest @Biocompare piece on multiplex assays: https://t.co/SrGWkCiyLU

[Serimmune @serimmune]

Our CTO John Shon was featured on @mendelspod with host @TheralDTimpson. They spoke about the latest applications of our #SERA technology and how it can impact the future of precision immunology:
https://t.co/lubrV9BhvV

#podcast #immunology #immunity #antibodies

[Serimmune @serimmune]

#WorldVaccineWest was the place to be! Check out photos from our Senior Director, Business Development Inger Larsen as she joined industry colleagues at this industry event. Looking forward to an exciting 2024!

#SERA #immuneprofiling #immunoassay

[Serimmune @serimmune]

What makes our #SERA platform unique? Uncover how it can be applied to test a variety of biomarkers for some of immunology’s most researched diseases.

Via Biocompare: https://t.co/CyCYitYVd3

#immuneprofiling #autoimmunedisease #cancerresearch

[Serimmune @serimmune]

What a fantastic time at #VaccineSummit! We enjoyed CTO John Shon’s presentation & making some great connections at our booth.

Missed us? Shoot us a message to learn more about #SERA here: https://t.co/1ExvH4WrYR

#vaccines #VaccineResearch #VaccineTechnology

[Serimmune @serimmune]

What makes our #SERA platform unique? Uncover how it can be applied to test a variety of biomarkers for some of immunology’s most researched diseases. Via @BioCompare: https://t.co/CyCYitYVd3

#immuneprofiling #autoimmunedisease #cancerresearch

[Serimmune @serimmune]

Who: CTO John Shon

What: “SERA: Universal serology enabling high-throughput, antigen agnostic studies of adaptive immune responses”

When: 11/14, 3:20pm

Where: #VaccineSummit 2023

Check it out & stop by our booth!

[Serimmune @serimmune]

#SITC2023 was informative, exciting & inspiring! We enjoyed connecting with colleagues to learn about the latest in #immunotherapy for cancer.

Couldn’t connect with us at the event, but want to know more about #SERA? Chat with our team: https://t.co/1ExvH4WrYR
#immuneprofiling

[Serimmune @serimmune]

#TeamSerimmune is ready for #VaccineSummit 2023! Our CTO John Shon will present on the #SERA platform on 11/14. Meet our team at our booth to learn more about our technology and how it can aid in vaccine development. We look forward to an exciting week!

https://t.co/qb6ikscpcm

[Serimmune @serimmune]

Who’s ready for #SITC2023? We’re here in San Diego this week at Booth 334. Stop by to discover how #SERA can support your research and initiatives. Can’t join us? Reach out to our team of experts: https://t.co/1ExvH4WrYR

#immuneprofiling #immunoassay #cancerresearch

[Serimmune @serimmune]

#TeamSerimmune takes on #SITC2023 in San Diego, 11/1-5. Engage with us at Booth 334 to discover how #SERA can support your research & initiatives.

Event info: https://t.co/OuIZKiFMm5

#immuneprofiling #immunoassay #cancerresearch

[Serimmune @serimmune]

Identifying antibody biomarkers is essential for the detection, stratification, & prognosis of conditions like #autoimmunedisease or #cancer. Uncover how our #SERA technology can be applied to test them via @BioCompare: https://t.co/CyCYitYVd3

#immuneprofiling